Induction of c-met proto-oncogene expression at the metastatic site

Clinical and Experimental Metastasis

Volumn 17, Issue 5, 1999, Pages 457-462

  Imai, Jun ichi ^a   Watanabe, Manabu ^b   Sasaki, Masahide ^a   Yamaguchi, Ryoji ^b   Tateyama, Susumu ^b   Sugano, Sumio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

C met proto oncogene; Differential display; HGF SF; Metastasis

Indexed keywords

ANIMAL CELL; ARTICLE; CELL INTERACTION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE INDUCTION; IN SITU HYBRIDIZATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; RECEPTOR UPREGULATION; STROMA CELL; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-MET; TUMOR CELLS, CULTURED;

EID: 0033378247     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006659515706     Document Type: Article

References (46)

1. 1. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980; 283: 139-46.
2. 2. Mignatti P, Rohhins E, Rifkin DB. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 1986; 47: 487-98.
3. 3. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
4. 4. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-73.
5. 5. Kerbel RS. Towards an understanding of the molecular basis of the melaslatic phenotype. Invasion Metastasis 1989; 9: 329-37.
6. 6. Fidler IJ, Radinsky R. Genetic control of cancer metastasis. J Natl Cancer Inst 1990; 82: 166-8.
7. 7. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 1991; 51: 5054s-9s.
8. 8. Grey AM, Schor AM, Rushton G et al. Purification of the migration-stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci USA 1989; 86: 2438-42.
9. 9. Ito A, Nakajima S, Sasaguri Y, Mori Y. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinase 1, 2 and 3 in fibroblasts. Br J Cancer 1995; 71: 1039-45.
10. 10. Steeg PS, Bevilacqua G, Kopper L et al. Evidence for a novel gene associated with low tumor metaslatic potential. J Natl Cancer Inst 1988; 80: 200-4.
11. 2+-binding protein family. Genes Dev 1989; 3: 1086-93.
12. 12. Pencil SD, Toh Y, Nicolson GL. Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treat 1993; 25: 165-74.
13. 13. Hashimoto Y, Shindo-Okada N, Tani N et al. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res 1996; 56: 5266-71.
14. 14. Cajot JF, Sordat I, Silvestre T, Sordat B. Differential display cloning identifies motility-related protein (NRP1/CD9) as highly expressed in primary compared to metaslatic human colon carcinoma cells. Cancer Res 1997; 57: 2593-7.
15. 15. Duncan LM, Deeds J, Hunter J et al. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 1998; 58: 1515-20.
16. 16. Liang L, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257: 967-70.
17. 17. Ito T, Kito K, Adati N et al. Fluorescent differential display: Arbitrarily primed RT-PCR fingerprinting on an automated DNA sequencer. FEBS Letters 1994; 351: 231-6.
18. 18. Simon HG, Oppenheimer S. Advanced mRNA differential display: isolation of a new differentially regulated myosin heavy chain-encoding gene in amphibian limb regeneration. Gene 1996; 172: 175-81.
19. 19. Takcuchi M, Kimoto M, Tashiro Y et al. Experimental and pathological studies of immunochemotherapy for curing of human cancer. Gan No Rinsho 1981; 27: 1227-36 [in Japanese].
20. 20. Armstrong PB, Quigley JP, Sidebottom E. Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines. Cancer Res 1982; 42: 1826-37.
21. 21. Liang L, Averboukh L, Pardee AB. Distribution and cloning of eukaryotic mRNAs by means of differential display: Refinements and optimization. Nucleic Acids Res 1993; 21: 3267-75.
22. 22. Altschul SF, Gish W, Miller W et al. Basic local alignment search tool. J Mol Biol 1990; 215: 403-10.
23. 23. Cooper CS, Park M, Blair DG et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984; 311: 29-33.
24. 24. Park M, Dean M, Kaul K et al. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 1987; 84: 6379-83.
25. 25. Picard O, Rolland Y, Poupon MF. Fibroblast-dependent tumorigenicity of cells in nude mice: Implication for implantation of metastases. Cancer Res 1986; 46: 3290-4.
26. 26. Camps JL, Chang S, Hsu TC et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA 1990; 87: 75-9.
27. 27. Moghul A, Liu L, Beedle A et al. Modulation of c-MET protooncogene (HGF receptor) mRNA abundance by cytokines and hormones: Evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 1994; 9: 2045-52.
28. 28. Zarnegar R. Regulation of HGF and HGFR gene expression. EXS 1995; 74: 33-49.
29. 29. Bardelli A, Longati P, Albero D et al. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J 1996; 15: 6205-12.
30. 30. Conner EA, Wirth PJ, Kiss A et al. Growth inhibition and induction of apoptosis by HGF in transformed rat liver epithelial cells. Biochem Biophys Res Commun 1997; 236: 396-401.
31. 31. Seslar SP, Nakamura T, Byers SW. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res 1993; 53: 1233-8.
32. 32. Nakamura T, Matsumoto K, Kiritoshi A et al. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions. Cancer Res 1997; 57: 3305-13.
33. 33. Weindner KM, Behrens J, Vandekerckhove J et al. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cell. J Cell Biol 1990; 111: 2097-8.
34. 34. Bellusci S, Moens G, Gaudino G et al. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 1994; 9: 1091-9.
35. 35. Rong S, Segal S, Anver M et al. Invasiveness and metastasis of NIH3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 1994; 91: 4731-5.
36. 36. Rosen EM, Knesel J, Goldberg ID et al. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer 1994; 57: 706-14.
37. 37. Jeffers M, Rong S, Vande Woude GK Enhanced tumorigenicity and invasion-metastasis by hepalocyte growth factor/scatter factor-met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 1996; 16: 1115-25.
38. 38. Date K, Matsumoto K, Kuba K et al. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 1998; 17: 3045-54.
39. 39. Di Renzo MF, Olivero M, Ferro S et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 1992; 7: 2549-53.
40. 40. Kuniyasu H, Yasui W, Kitadai Y et al. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 1992; 189: 227-32.
41. 41. Natali PG, Nicotra MR, Di Renzo MF et al. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: Demonstration of the relationship to malignant melanoma tumor progression. Br J Cancer 1993; 68: 746-50.
42. 42. Rong S, Jeffers M, Resau JH et al. Met expression and sarcoma tumorigenicity. Cancer Res 1993; 53: 5355-60.
43. 43. Yamashita J, Ogawa M, Yamashita S et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994; 54: 1930-3.
44. 44. Rong S, Donehower LA, Hansen MF et al. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res 1995; 55: 1963-70.
45. 45. Ferracini R, Olivero M, Di Renzo MF et al. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 1996; 12: 1697-705.
46. 46. Tuck AB, Park M, Sterns EF et al. Coexprcssion of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 1996; 148: 225-32.